CARDIFF ONCOLOGY INC (CRDF) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:CRDF • US14147L1089

1.6 USD
+0.12 (+8.11%)
At close: Feb 6, 2026
1.58 USD
-0.02 (-1.25%)
After Hours: 2/6/2026, 8:26:29 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CRDF revenue by date.CRDF revenue by date.
390K
8.33%
488K
25.13%
683K
39.96%
470.332K
-31.14%
339.15K
-27.89%
163.924K
-51.67%
102K
-37.78%
103.54M
101,409.80%
315.96M
205.16%
460.25M
45.67%
670.49M
45.68%
890.75M
32.85%
EBITDA
YoY % growth
CRDF ebitda by date.CRDF ebitda by date.
-39.66M
-39.60%
-45.014M
-13.50%
-48.247M
-7.18%
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CRDF ebit by date.CRDF ebit by date.
-39.9M
-38.25%
-45.412M
-13.81%
-48.651M
-7.13%
-55.861M
-14.82%
-60.289M
-7.93%
-79.926M
-32.57%
-156.229M
-95.47%
-126.907M
18.77%
-29.057M
77.10%
88.858M
405.81%
271.17M
205.17%
462.13M
70.42%
Operating Margin
CRDF operating margin by date.CRDF operating margin by date.
-10,230.77%-9,305.74%-7,123.13%-11,876.99%-17,776.48%-48,758.10%-153,165.50%-122.57%-9.20%19.31%40.44%51.88%
EPS
YoY % growth
CRDF eps by date.CRDF eps by date.
-0.89
-25.35%
-0.93
-4.49%
-0.95
-2.15%
-0.78
17.54%
-0.78
0.39%
-0.94
-20.26%
-1.36
-44.57%
-1.51
-11.28%
-0.36
76.35%
0.45
225.71%
1.34
197.73%
2.25
68.70%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth
-0.19
12.84%
-0.18
7.95%
-0.18
12.09%
-0.19
-14.40%
-0.21
-7.71%
-0.22
-21.88%
-0.23
-24.31%
-0.23
-20.63%
-0.24
-18.52%
-0.28
-22.73%
-0.32
-37.78%
-0.34
-43.48%
Revenue
Q2Q % growth
96.9K
-35.83%
81.6K
-25.14%
81.6K
-32.56%
81.6K
-32.00%
81.6K
-15.79%
102K
25.00%
102K
25.00%
102K
25.00%
102K
25.00%
N/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-13.355M
-2.73%
-13.881M
3.48%
-14.568M
1.41%
-15.298M
-27.76%
-16.349M
-22.41%
-18.768M
-35.21%
-19.788M
-35.83%
-20.808M
-36.02%
-21.318M
-30.40%
N/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.17
32.00%
-0.210.0418.55%
Q2 2025
Q2Q % growth
-0.21
19.23%
-0.20-0.01-6.95%
Q1 2025
Q2Q % growth
-0.20
9.09%
-0.19-0.01-5.25%
Q4 2024
Q2Q % growth
-0.22
-4.76%
-0.250.0310.75%
Q3 2024
Q2Q % growth
-0.25
-13.64%
-0.280.039.22%
Q2 2024
Q2Q % growth
-0.26
-4.00%
-0.25-0.01-2.99%
Q1 2024
Q2Q % growth
-0.22
12.00%
-0.250.0312.85%
Q4 2023
Q2Q % growth
-0.21
-5.00%
-0.280.0725.81%
Q3 2023
Q2Q % growth
-0.22
-10.00%
-0.290.0724.32%
Q2 2023
Q2Q % growth
-0.25
-4.17%
-0.260.015.44%
Q1 2023
Q2Q % growth
-0.25 -0.23-0.02-8.45%
Q4 2022
Q2Q % growth
-0.20
13.04%
-0.240.0416.56%
Q3 2022
Q2Q % growth
-0.20
-17.65%
-0.270.0725.73%
Q2 2022
Q2Q % growth
-0.24
-41.18%
-0.260.026.70%
Q1 2022
Q2Q % growth
-0.25
-78.57%
-0.24-0.01-6.10%
Q4 2021
Q2Q % growth
-0.23
-21.05%
-0.18-0.05-31.35%
Q3 2021
Q2Q % growth
-0.17
10.53%
-0.170.001.96%
Q2 2021
Q2Q % growth
-0.17
66.67%
-0.15-0.02-11.30%
Q1 2021
Q2Q % growth
-0.14 -0.150.016.95%
Q4 2020
Q2Q % growth
-0.19 -0.14-0.05-33.05%
Q3 2020
Q2Q % growth
-0.19 -0.190.000.21%
Q2 2020
Q2Q % growth
-0.51 -0.24-0.27-108.33%
CRDF Yearly EPS VS EstimatesCRDF Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -20 -40 -60 -80
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
120K
-27.27%
108.375K11.625K10.73%
Q2 2025
Q2Q % growth
121K
-25.77%
108.375K12.625K11.65%
Q1 2025
Q2Q % growth
109K
-46.83%
98.359K10.641K10.82%
Q4 2024
Q2Q % growth
151K
-3.21%
96.053K54.947K57.20%
Q3 2024
Q2Q % growth
165K
17.02%
81.6K83.4K102.21%
Q2 2024
Q2Q % growth
163K
50.93%
59.925K103.075K172.01%
Q1 2024
Q2Q % growth
205K
146.99%
56.1K148.9K265.42%
Q4 2023
Q2Q % growth
156K
20.00%
38.25K117.75K307.84%
Q3 2023
Q2Q % growth
141K
56.67%
51K90K176.47%
Q2 2023
Q2Q % growth
108K
20.00%
51K57K111.76%
Q1 2023
Q2Q % growth
83K
18.57%
56.712K26.288K46.35%
Q4 2022
Q2Q % growth
130K 74.715K55.285K73.99%
Q3 2022
Q2Q % growth
90K 69.564K20.436K29.38%
Q2 2022
Q2Q % growth
90K
28.57%
66.096K23.904K36.17%
Q1 2022
Q2Q % growth
70K 48.113K21.887K45.49%
Q4 2021
Q2Q % growth
130K
8.33%
43.35K86.65K199.88%
Q3 2021
Q2Q % growth
90K
-35.71%
30.6K59.4K194.12%
Q2 2021
Q2Q % growth
70K
75.00%
155.55K-85.55K-55.00%
Q1 2021
Q2Q % growth
70K 155.55K-85.55K-55.00%
Q4 2020
Q2Q % growth
120K 33.15K86.85K261.99%
Q3 2020
Q2Q % growth
140K 33.997K106.003K311.81%
CRDF Yearly Revenue VS EstimatesCRDF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.47% 12.81% 0.12% 8.07%
Revenue-10% -15.56% 0% 6%